Germain Michel A, Bonvalot Sylvie, Rimareix Françoise, Missana Christine-Marie
Département de chirurgie oncologique, Institut Gustave Roussy, 39, Rue Camille Desmoulins, F 94805 Villejuif cedex.
Bull Acad Natl Med. 2010 Jan;194(1):51-65; discussion 65-7.
We retrospectively studied the benefits of isolated limb perfusion combined with TNFalpha administration and free flap reconstruction in locally advanced soft-tissue sarcomas of the limbs. Between 2000 and 2008, we treated 37 patients (22 women and 15 men) with locally advanced soft tissue sarcomas. The sarcomas were located in the lower and upper limbs in respectively 26 and 11 cases, and had a mean diameter of 15 cm and 12 cm, respectively. They were multifocal in 8 cases and recurrent in 15 cases. Seventeen patients received neoadjuvant chemotherapy. Sarcoma excision was combined with a complementary procedure in 10 patients (vascular graft or nerve anastomosis). Reconstruction was performed with free flaps of the latissimus dorsi (n = 31), transverse rectus abdominis myocutaneous flaps (n = 4) or free forearm flaps (n = 2). Early postoperative radiotherapy was administered in 25 cases. Three major improvements were made in recent years, namely isolated limb perfusion, TNFalpha administration, and free flap reconstruction two months after resection of residual sarcoma. There were no early postoperative deaths. The procedure lasted a median of 7 hours. Two free flaps necrotized, and a new free flap was created with success. Tumor excision was stage R0 in 29 cases (clean margins), R1 in 7 cases (microscopic residue), and R2 in one case (macroscopic residue). With a median follow-up of 5 years, there were no local recurrences in R0 patients, and the overall survival rate was 65%. The limb was preserved in 78% of cases. Thirteen patients developed pulmonary metastases and seven of them died between the first and fifth years of follow-up. Isolated limb perfusion and free flap reconstruction permitted more extensive tumor excision. Amputation was avoided in 78% of our 37 patients, and early postoperative radiotherapy was possible in 25 cases.
我们回顾性研究了肢体隔离灌注联合肿瘤坏死因子α(TNFα)给药及游离皮瓣重建术在肢体局部晚期软组织肉瘤治疗中的益处。2000年至2008年间,我们治疗了37例局部晚期软组织肉瘤患者(22例女性和15例男性)。肉瘤分别位于下肢26例和上肢11例,平均直径分别为15 cm和12 cm。其中8例为多灶性,15例为复发性。17例患者接受了新辅助化疗。10例患者(血管移植或神经吻合)的肉瘤切除联合了补充手术。采用背阔肌游离皮瓣(n = 31)、腹直肌横形肌皮瓣(n = 4)或游离前臂皮瓣(n = 2)进行重建。25例患者术后早期接受了放疗。近年来有三项主要改进,即肢体隔离灌注、TNFα给药以及残留肉瘤切除术后两个月的游离皮瓣重建。术后早期无死亡病例。手术中位持续时间为7小时。2例游离皮瓣坏死,成功进行了新的游离皮瓣再造。29例患者肿瘤切除达到R0期(切缘阴性),7例为R1期(镜下残留),1例为R2期(肉眼残留)。中位随访5年,R0期患者无局部复发,总生存率为65%。78%的病例肢体得以保留。13例患者发生肺转移,其中7例在随访的第1年至第5年间死亡。肢体隔离灌注和游离皮瓣重建使肿瘤切除范围更广。我们的37例患者中,78%避免了截肢,25例患者术后早期可行放疗。